The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nuvama Crossover Opportunities Fund Series III & Others
29-Jul-2026
Download PDF
Sudeep Pharma
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nuvama Crossover Opportunities Fund Series III & Others